Skip to content

Rewarding Sexually Transmitted Infection (STI) Prevention and Control in Tanzania

Encouraging Safe Sexual Practices Among Youth Using Cash Rewards: A Randomized Trial in the Kilombero/Ulanga Districts, Tanzania

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00922038
Acronym
RESPECT
Enrollment
2411
Registered
2009-06-17
Start date
2009-02-28
Completion date
Unknown
Last updated
2009-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexually Transmitted Diseases

Brief summary

This project evaluates the effect of a combined economic and psycho-social intervention to reduce risky sexual activity and its consequences. The main hypothesis to be tested is that risky sexual activity and resulting sexually transmitted infections (STIs) can be reduced through an intervention of counseling, regular STI testing, and positive reinforcement using cash rewards. The intervention is being implemented in a population of young people in rural Tanzania where more conventional behavioral change interventions have had limited effect in battling a generalized HIV epidemic.

Interventions

BEHAVIORALCash reward

Enrollees testing negative for treatable sexually transmitted infections will receive cash rewards.

Sponsors

World Bank
CollaboratorOTHER
Health Effects Institute
CollaboratorOTHER
William and Flora Hewlett Foundation
CollaboratorOTHER
Population Health Research Institute
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
RTI International
CollaboratorOTHER
University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Plan to live in study area for next 12 months

Exclusion criteria

* Pregnant

Design outcomes

Primary

MeasureTime frame
Prevalence of sexually transmitted infections measured in laboratory testing (Chlamydia, Gonorrhea, Syphilis, Trichomonas, Mycoplasma genitalium, HSV-2, HIV)4, 8, and 12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026